Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 209, pseudogene (RN7SL209P)

Target
RN7SL209P
Molecular classification
Pseudogene, Noncoding RNA (ncRNA), Other
01

Overview

RN7SL209P is a human pseudogene closely related to the canonical 7SL RNA gene. The canonical 7SL RNA is integral to the Signal Recognition Particle (SRP), a ribonucleoprotein involved in cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells[1][5]. RN7SL209P, as a pseudogene, is a noncoding RNA sequence that has lost its original function and does not encode a functional RNA or protein product. 7SL RNA pseudogenes typically arise by reverse transcription of 7SL RNA followed by insertion into genomic DNA, often showing truncations at either the 5’ or 3’ ends[3][8]. While some pseudogenes in the human genome may play regulatory roles—such as serving as competitive endogenous RNAs (ceRNAs), miRNA sponges, or having tissue-specific expression—there is no direct evidence that RN7SL209P shows such activity[2][4][6][9]. The majority of 7SL-like sequences in human DNA are pseudogenes, and only a small number actually encode the functional SRP RNA[8][9]. RN7SL209P is not considered a therapeutic target, receptor, or enzyme, and is not associated with human disease or pharmacological intervention.

Other names
RN7SL209PRNA, 7SL, cytoplasmic 209, pseudogene7SL pseudogene
02

Mechanism of action

Not applicable; not a canonical drug target

03

Biological functions

None established for RN7SL209P itselfParent 7SL RNA: component of Signal Recognition Particle (SRP), global regulator of SRP-mediated protein translocationSome pseudogenes may serve as miRNA “sponges” or regulate gene expression, but no evidence specifically for RN7SL209P
04

Disease associations

None established for RN7SL209PSome pseudogenes’ ncRNAs are implicated in cancer and gene regulation, but not specifically for RN7SL209P
05

Safety considerations

Not applicable
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 209, pseudogene (RN7SL209P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 209, pseudogene (RN7SL209P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call